The Energy and Commerce Subcommittee on Energy and Power will host a forum next Thursday entitled “Geopolitical Implications and Mutual Benefits of U.S. LNG Exports.” Representatives from several foreign countries and the U.S. territory of Puerto Rico will participate in the forum, providing an opportunity for members to hear a broad range of international perspectives on U.S.
WASHINGTON, DC – Energy and Commerce Committee leaders last week followed up on a previous committee staff request for briefings on the administration’s efforts and coordination regarding the use of cost estimates for the social cost of carbon (SCC) from agencies participating in an “Interagency Working Group on the Social Cost of Carbon.” According to the Environmental Protection Agency (EPA), “the SCC is an estimate of the economic damages associated” with increases in carbon d
WASHINGTON, DC – The House of Representatives today passed H.R. 3204, the Drug Quality and Security Act, by a voice vote. The legislation, sponsored by Energy and Commerce Committee Chairman Fred Upton (R-MI), is the product of a thoughtful, bipartisan, bicameral effort to improve drug safety and help prevent a future public health crisis like the 2012 deadly meningitis outbreak tied to the New England Compounding Center (NECC).
WASHINGTON, DC – House Energy and Commerce Committee Chairman Fred Upton (R-MI) today kicked off debate on the bipartisan H.R. 3204, the Drug Quality and Security Act.
WASHINGTON, DC – The House Committee on Energy and Commerce today announced its hearing schedule for the week of September 30, 2013. The Communications and Technology Subcommittee will continue its spectrum oversight and the Energy and Power Subcommittee will hold a hearing on bipartisan legislation that would consolidate and modernize the cross-boundary approval process for energy infrastructure projects.
“This compromise legislation addresses the issues that led to the NECC tragedy, protects the physician-patient-pharmacist relationship, maintains critical patient access to compounded medications, and strengthens the pharmaceutical supply chain.” - NCPA